These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 17085491

  • 41. In silico study of carvone derivatives as potential neuraminidase inhibitors.
    Jusoh N, Zainal H, Abdul Hamid AA, Bunnori NM, Abd Halim KB, Abd Hamid S.
    J Mol Model; 2018 Mar 15; 24(4):93. PubMed ID: 29546582
    [Abstract] [Full Text] [Related]

  • 42. Correlation analyses on binding affinity of sialic acid analogues and anti-influenza drugs with human neuraminidase using ab initio MO calculations on their complex structures--LERE-QSAR analysis (IV).
    Hitaoka S, Matoba H, Harada M, Yoshida T, Tsuji D, Hirokawa T, Itoh K, Chuman H.
    J Chem Inf Model; 2011 Oct 24; 51(10):2706-16. PubMed ID: 21870866
    [Abstract] [Full Text] [Related]

  • 43. Theoretical studies on the susceptibility of oseltamivir against variants of 2009 A/H1N1 influenza neuraminidase.
    Li L, Li Y, Zhang L, Hou T.
    J Chem Inf Model; 2012 Oct 22; 52(10):2715-29. PubMed ID: 22998323
    [Abstract] [Full Text] [Related]

  • 44. The binding properties of the H5N1 influenza virus neuraminidase as inferred from molecular modeling.
    Raab M, Tvaroška I.
    J Mol Model; 2011 Jun 22; 17(6):1445-56. PubMed ID: 20853123
    [Abstract] [Full Text] [Related]

  • 45. Insights from investigating the interaction of oseltamivir (Tamiflu) with neuraminidase of the 2009 H1N1 swine flu virus.
    Wang SQ, Du QS, Huang RB, Zhang DW, Chou KC.
    Biochem Biophys Res Commun; 2009 Aug 28; 386(3):432-6. PubMed ID: 19523442
    [Abstract] [Full Text] [Related]

  • 46. Inhibitor selectivity of a new class of oseltamivir analogs against viral neuraminidase over human neuraminidase enzymes.
    Albohy A, Mohan S, Zheng RB, Pinto BM, Cairo CW.
    Bioorg Med Chem; 2011 May 01; 19(9):2817-22. PubMed ID: 21489803
    [Abstract] [Full Text] [Related]

  • 47. Insight into the oseltamivir resistance R292K mutation in H5N1 influenza virus: a molecular docking and molecular dynamics approach.
    Karthick V, Ramanathan K.
    Cell Biochem Biophys; 2014 Mar 01; 68(2):291-9. PubMed ID: 23794010
    [Abstract] [Full Text] [Related]

  • 48. Dynamic residue interaction network analysis of the oseltamivir binding site of N1 neuraminidase and its H274Y mutation site conferring drug resistance in influenza A virus.
    Yadav M, Igarashi M, Yamamoto N.
    PeerJ; 2021 Mar 01; 9():e11552. PubMed ID: 34141489
    [Abstract] [Full Text] [Related]

  • 49. Rational design of Tamiflu derivatives targeting at the open conformation of neuraminidase subtype 1.
    Li Y, Zhou B, Wang R.
    J Mol Graph Model; 2009 Oct 01; 28(3):203-19. PubMed ID: 19656699
    [Abstract] [Full Text] [Related]

  • 50. Surveillance for neuraminidase inhibitor resistance in human influenza viruses from Australia.
    Hurt AC, Barr IG, Durrant CJ, Shaw RP, Sjogren HM, Hampson AW.
    Commun Dis Intell Q Rep; 2003 Oct 01; 27(4):542-7. PubMed ID: 15508516
    [Abstract] [Full Text] [Related]

  • 51. Three-dimensional structure of neuraminidase of subtype N9 from an avian influenza virus.
    Baker AT, Varghese JN, Laver WG, Air GM, Colman PM.
    Proteins; 1987 Oct 01; 2(2):111-7. PubMed ID: 3447170
    [Abstract] [Full Text] [Related]

  • 52. Anti-influenza virus activity of peramivir in mice with single intramuscular injection.
    Bantia S, Arnold CS, Parker CD, Upshaw R, Chand P.
    Antiviral Res; 2006 Jan 01; 69(1):39-45. PubMed ID: 16325932
    [Abstract] [Full Text] [Related]

  • 53. Correlation analyses on binding affinity of sialic acid analogues with influenza virus neuraminidase-1 using ab initio MO calculations on their complex structures.
    Hitaoka S, Harada M, Yoshida T, Chuman H.
    J Chem Inf Model; 2010 Oct 25; 50(10):1796-805. PubMed ID: 20863103
    [Abstract] [Full Text] [Related]

  • 54. Computational Study of Drug Binding Affinity to Influenza A Neuraminidase Using Smooth Reaction Path Generation (SRPG) Method.
    Nguyen H, Tran T, Fukunishi Y, Higo J, Nakamura H, Le L.
    J Chem Inf Model; 2015 Sep 28; 55(9):1936-43. PubMed ID: 26247106
    [Abstract] [Full Text] [Related]

  • 55. Binding mode analysis of anti-influenza drugs in H1N1 (2009) and H5N1 influenza A virus and designing of potential H1N1 inhibitors.
    Singh KhD, Kirubakaran P, Nagamani S, Karthikeyan M.
    Int J Comput Biol Drug Des; 2015 Sep 28; 8(1):1-18. PubMed ID: 25869316
    [Abstract] [Full Text] [Related]

  • 56. A novel small-molecule inhibitor of the avian influenza H5N1 virus determined through computational screening against the neuraminidase.
    An J, Lee DC, Law AH, Yang CL, Poon LL, Lau AS, Jones SJ.
    J Med Chem; 2009 May 14; 52(9):2667-72. PubMed ID: 19419201
    [Abstract] [Full Text] [Related]

  • 57. Synthesis of tamiflu and its phosphonate congeners possessing potent anti-influenza activity.
    Shie JJ, Fang JM, Wang SY, Tsai KC, Cheng YS, Yang AS, Hsiao SC, Su CY, Wong CH.
    J Am Chem Soc; 2007 Oct 03; 129(39):11892-3. PubMed ID: 17850083
    [No Abstract] [Full Text] [Related]

  • 58. Recent advances in neuraminidase inhibitor development as anti-influenza drugs.
    Feng E, Ye D, Li J, Zhang D, Wang J, Zhao F, Hilgenfeld R, Zheng M, Jiang H, Liu H.
    ChemMedChem; 2012 Sep 03; 7(9):1527-36. PubMed ID: 22807317
    [Abstract] [Full Text] [Related]

  • 59. Neuraminidase inhibitor R-125489--a promising drug for treating influenza virus: steered molecular dynamics approach.
    Mai BK, Li MS.
    Biochem Biophys Res Commun; 2011 Jul 08; 410(3):688-91. PubMed ID: 21693105
    [Abstract] [Full Text] [Related]

  • 60. Susceptibility of human influenza viruses from Australasia and South East Asia to the neuraminidase inhibitors zanamivir and oseltamivir.
    Hurt AC, Barr IG, Hartel G, Hampson AW.
    Antiviral Res; 2004 Apr 08; 62(1):37-45. PubMed ID: 15026200
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.